• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板衍生因子 V 是动脉血栓形成的关键介质。

Platelet-Derived Factor V Is a Critical Mediator of Arterial Thrombosis.

机构信息

Drug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.

Department of Medicine, University of Missouri School of Medicine, Columbia, MO.

出版信息

J Am Heart Assoc. 2017 Jul 3;6(7):e006345. doi: 10.1161/JAHA.117.006345.

DOI:10.1161/JAHA.117.006345
PMID:28673898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5586322/
Abstract

BACKGROUND

Coagulation factor V (FV) plays a key role in hemostasis, is present in plasma and platelets, and has both pro- and anticoagulant properties; however, the contribution of platelet-derived FV to arterial thrombosis remains undetermined.

METHODS AND RESULTS

Using transgenic mice with various levels of FV gene expression that was restricted to the plasma or platelets, the roles of platelet FV were evaluated in the regulation of arterial thrombosis and platelet activation. Mice with higher levels of platelet FV exhibited faster thrombotic occlusion of the carotid artery after injury compared with mice with lower platelet FV levels. Infusion of platelets with higher levels of FV into transgenic mice with undetectable levels of platelet FV reduced the time to carotid artery occlusion. In contrast, infusion of purified recombinant plasma FV into mice with undetectable platelet FV levels failed to reduce the carotid occlusion times following injury. Evaluation of isolated platelets revealed that platelet-derived FV was critical for the regulation of platelet activation. These effects were associated with an increased level of expression of P-selectin and increased cGMP in platelets.

CONCLUSIONS

We established that platelet-derived FV is a critical mediator of arterial thrombosis that involves platelet activation.

摘要

背景

凝血因子 V(FV)在止血中起着关键作用,存在于血浆和血小板中,具有促凝和抗凝特性;然而,血小板衍生的 FV 对动脉血栓形成的贡献仍未确定。

方法和结果

使用转基因小鼠,其 FV 基因表达水平受到限制,仅限于血浆或血小板,评估了血小板 FV 在调节动脉血栓形成和血小板激活中的作用。与血小板 FV 水平较低的小鼠相比,血小板 FV 水平较高的小鼠在损伤后颈动脉血栓形成的闭塞更快。将 FV 水平较高的血小板输注到血小板 FV 水平检测不到的转基因小鼠中,可缩短颈动脉闭塞时间。相比之下,将纯化的重组血浆 FV 输注到血小板 FV 水平检测不到的小鼠中,不能减少损伤后颈动脉闭塞时间。对分离的血小板进行评估发现,血小板衍生的 FV 对血小板激活的调节至关重要。这些作用与 P-选择素表达水平的增加和血小板中环鸟苷酸(cGMP)的增加有关。

结论

我们确定了血小板衍生的 FV 是涉及血小板激活的动脉血栓形成的关键介质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/2da162a75675/JAH3-6-e006345-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/a5c6db1b8837/JAH3-6-e006345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/e39465cf1c02/JAH3-6-e006345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/dd2dac75600c/JAH3-6-e006345-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/b1d7ec244348/JAH3-6-e006345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/2da162a75675/JAH3-6-e006345-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/a5c6db1b8837/JAH3-6-e006345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/e39465cf1c02/JAH3-6-e006345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/dd2dac75600c/JAH3-6-e006345-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/b1d7ec244348/JAH3-6-e006345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d7/5586322/2da162a75675/JAH3-6-e006345-g005.jpg

相似文献

1
Platelet-Derived Factor V Is a Critical Mediator of Arterial Thrombosis.血小板衍生因子 V 是动脉血栓形成的关键介质。
J Am Heart Assoc. 2017 Jul 3;6(7):e006345. doi: 10.1161/JAHA.117.006345.
2
Absence of transforming growth factor beta 1 in murine platelets reduces neointima formation without affecting arterial thrombosis.缺乏转化生长因子-β1 的小鼠血小板可减少新内膜形成,而不影响动脉血栓形成。
Thromb Haemost. 2017 Aug 31;117(9):1782-1797. doi: 10.1160/TH17-02-0112.
3
Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.比索洛尔刺激血小板产生一氧化氮可预防血栓形成。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):820-9. doi: 10.1161/ATVBAHA.114.303290. Epub 2014 Feb 20.
4
Epidermal growth factor-like repeats of SCUBE1 derived from platelets are critical for thrombus formation.血小板衍生的 SCUBE1 表皮生长因子样重复序列对于血栓形成至关重要。
Cardiovasc Res. 2020 Jan 1;116(1):193-201. doi: 10.1093/cvr/cvz036.
5
Platelet-derived factor V promotes angiogenesis in a mouse hind limb ischemia model.血小板衍生因子V在小鼠后肢缺血模型中促进血管生成。
J Vasc Surg. 2017 Apr;65(4):1180-1188.e1. doi: 10.1016/j.jvs.2016.03.453. Epub 2016 May 27.
6
TMEM16F-Mediated Platelet Membrane Phospholipid Scrambling Is Critical for Hemostasis and Thrombosis but not Thromboinflammation in Mice-Brief Report.TMEM16F介导的血小板膜磷脂翻转对小鼠止血和血栓形成至关重要,但对血栓炎症并非如此——简要报告
Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2152-2157. doi: 10.1161/ATVBAHA.116.307727. Epub 2016 Sep 15.
7
Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.将血友病A基因疗法的凝血因子VIII表达靶向至血小板在小鼠中不会引发明显的血栓形成风险。
J Thromb Haemost. 2017 Jan;15(1):98-109. doi: 10.1111/jth.13436. Epub 2016 Nov 8.
8
ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formation.ARHGEF10 基因敲除抑制血小板聚集并保护小鼠免于血栓形成。
J Thromb Haemost. 2017 Oct;15(10):2053-2064. doi: 10.1111/jth.13799. Epub 2017 Sep 18.
9
NADPH Oxidases Are Required for Full Platelet Activation In Vitro and Thrombosis In Vivo but Dispensable for Plasma Coagulation and Hemostasis.NADPH 氧化酶在体外血小板完全活化和体内血栓形成中是必需的,但在血浆凝固和止血中是可有可无的。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):683-697. doi: 10.1161/ATVBAHA.120.315565. Epub 2020 Dec 3.
10
Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.血小板蛋白 S 通过控制血栓中的凝血来限制静脉血栓形成倾向,但不限制动脉血栓形成倾向。
Blood. 2020 May 28;135(22):1969-1982. doi: 10.1182/blood.2019003630.

引用本文的文献

1
The role of factor V in trauma-induced coagulopathy: an observational and experimental study.凝血因子V在创伤性凝血病中的作用:一项观察性和实验性研究。
Res Pract Thromb Haemost. 2025 Apr 17;9(4):102857. doi: 10.1016/j.rpth.2025.102857. eCollection 2025 May.
2
Skin Telocytes Could Fundament the Cellular Mechanisms of Wound Healing in Platelet-Rich Plasma Administration.皮肤 Telocytes 可能为富血小板血浆治疗中伤口愈合的细胞机制提供基础。
Cells. 2024 Aug 8;13(16):1321. doi: 10.3390/cells13161321.
3
Acute Myocardial Infarction in Patients with Hereditary Thrombophilia-A Focus on Factor V Leiden and Prothrombin G20210A.

本文引用的文献

1
Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation.蛋白二硫键异构酶抑制通过干扰血小板因子 V 的激活来阻断人类凝血酶的生成。
JCI Insight. 2017 Jan 12;2(1):e89373. doi: 10.1172/jci.insight.89373.
2
Platelet-derived factor V promotes angiogenesis in a mouse hind limb ischemia model.血小板衍生因子V在小鼠后肢缺血模型中促进血管生成。
J Vasc Surg. 2017 Apr;65(4):1180-1188.e1. doi: 10.1016/j.jvs.2016.03.453. Epub 2016 May 27.
3
Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.
遗传性易栓症患者的急性心肌梗死——聚焦于凝血因子V莱顿突变和凝血酶原G20210A突变
Life (Basel). 2023 Jun 12;13(6):1371. doi: 10.3390/life13061371.
4
Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials.血管性血友病因子 Leiden 突变与接受抗血小板治疗的急性冠状动脉综合征患者出血风险:3 项随机临床试验的汇总分析。
J Am Heart Assoc. 2021 Sep 7;10(17):e021115. doi: 10.1161/JAHA.120.021115. Epub 2021 Aug 28.
5
Linagliptin Regulates the Mitochondrial Respiratory Reserve to Alter Platelet Activation and Arterial Thrombosis.利格列汀调节线粒体呼吸储备以改变血小板活化和动脉血栓形成。
Front Pharmacol. 2020 Nov 30;11:585612. doi: 10.3389/fphar.2020.585612. eCollection 2020.
6
Platelet-Derived Factor V Is an Important Determinant of the Metastatic Potential of Circulating Tumor Cells.血小板衍生因子V是循环肿瘤细胞转移潜能的重要决定因素。
Front Oncol. 2020 Sep 23;10:558306. doi: 10.3389/fonc.2020.558306. eCollection 2020.
7
Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.抗血栓治疗:动脉粥样硬化和动脉血栓形成的预防和治疗。
Handb Exp Pharmacol. 2022;270:103-130. doi: 10.1007/164_2020_357.
8
Microfluidic endothelium-on-a-chip development, from in vivo to in vitro experimental models.微流控芯片内皮细胞的发展,从体内到体外实验模型。
Rom J Morphol Embryol. 2020;61(1):15-23. doi: 10.47162/RJME.61.1.02.
9
Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease.急性冠状动脉综合征与稳定型冠状动脉疾病的血小板释放物蛋白质组学比较分析
Front Cardiovasc Med. 2020 Jun 24;7:101. doi: 10.3389/fcvm.2020.00101. eCollection 2020.
10
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data.因子 V Leiden 与随后的动脉粥样血栓事件的关联:个体参与者数据的 GENIUS-CHD 研究。
Circulation. 2020 Aug 11;142(6):546-555. doi: 10.1161/CIRCULATIONAHA.119.045526. Epub 2020 Jul 13.
血小板和血小板衍生的因子Va在完全缺乏因子V的情况下赋予止血能力。
Blood. 2015 Jun 4;125(23):3647-50. doi: 10.1182/blood-2014-07-589580. Epub 2015 Apr 20.
4
Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.巨核细胞内吞血浆来源的因子 V 后对其进行蛋白水解,形成血小板来源的因子 V/Va 池。
J Thromb Haemost. 2013 Aug;11(8):1532-9. doi: 10.1111/jth.12307.
5
Mechanisms underlying FeCl3-induced arterial thrombosis.三氯化铁诱导动脉血栓形成的机制。
J Thromb Haemost. 2011 Apr;9(4):779-89. doi: 10.1111/j.1538-7836.2011.04218.x.
6
Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis.组织因子途径抑制剂与因子V水平之间的相互作用对静脉血栓形成风险的影响。
J Thromb Haemost. 2010 May;8(5):1130-2. doi: 10.1111/j.1538-7836.2010.03805.x. Epub 2010 Feb 11.
7
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.严重先天性因子 V 缺乏症伴轻度出血症状患者中残留的血小板因子 V 可确保凝血酶生成。
Blood. 2010 Jan 28;115(4):879-86. doi: 10.1182/blood-2009-08-237719. Epub 2009 Oct 27.
8
Reduced thrombin generation increases host susceptibility to group A streptococcal infection.凝血酶生成减少会增加宿主对A组链球菌感染的易感性。
Blood. 2009 Feb 5;113(6):1358-64. doi: 10.1182/blood-2008-07-170506. Epub 2008 Dec 3.
9
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.血小板反应蛋白-1通过阻断一氧化氮/cGMP信号通路的抗血栓形成活性来刺激血小板聚集。
Blood. 2008 Jan 15;111(2):613-23. doi: 10.1182/blood-2007-06-098392. Epub 2007 Sep 21.
10
Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3.环磷酸鸟苷依赖性蛋白激酶对p38和ERK途径的顺序激活导致血小板整合素αIIbβ3的激活。
Blood. 2006 Feb 1;107(3):965-72. doi: 10.1182/blood-2005-03-1308. Epub 2005 Oct 6.